Cranberry Ingredient Gets EU Medical UTI Claim

May 2, 2012

Medical Brands (Amsterdam) and Decas Botanical Synergies (Carver, MA) have earned EU medical device status for their Cranberry-Active Bladder Capsules, intended to treat or prevent urinary tract infections (UTIs).

Medical Brands (Amsterdam) and Decas Botanical Synergies (Carver, MA) have earned EU medical device status for their Cranberry-Active Bladder Capsules, intended to treat or prevent urinary tract infections (UTIs).

The European Food Safety Authority (EFSA; Parma, Italy) recently rejected a health claim for cranberries and defense against bacterial pathogens. That rejection, soon to enter into law, can only help the market success of Cranberry-Active Bladder Capsules.

Antibiotics still remain a viable market alternative for UTI health, but published science indicates that their use can lead to the body’s increased resistance of other antibiotics.

“As a registered Class IIa medical device, Cranberry-Active is the only cranberry-based product in the European Economic Area and recognized countries that can be freely marketed with a medical claim for treating and preventing urinary tract infections,” said the two companies in a joint press release.

Medical Brands and Decas will present an information seminar on their product at Vitafoods Europe in Geneva later this month (Tuesday, May 22, 2pm).